Nanotechnology is beginning to leave the laboratory and hit the high street – but health scares could stop this commercialisation process in its tracks.
With much of their work not qualifying for federal money, US states leading the charge in stem cell research are holding out the tin cup to get donations.
A team at the École des Mines in France is looking for partners to develop new applications for metal foams, including one to clean up the exhaust gases of diesel vehicles.
Italian researchers have designed a small-sized humanoid robot to test a model of the human sense of "presence". They are now looking for investors to take the technology for further development.
A new three-dimensional microscope gives insight into internal structure and chemical composition, revealing how materials are affected, over time, by changes in temperature, humidity, weight load and other conditions.
French and Belgian researchers have genetically modified strains of the bacteria as treatments for human gastrointestinal disorderse – and are keen to form licensing and partnering deals to take this research forward.
A new high-speed electronic network is set to transform collaboration between 45 million researchers and students in Europe and China when it goes live later this year.
EBI Food Safety claims it is taking a quantum leap in the fight against bacteria with the establishment of the first west European facility for industrial-scale production of bacteriophages.
A Danish biopharmaceutical company and the University of Copenhagen, Denmark, have set up the MicroRNA Research Consortium, with funding from the Danish Advanced Technology Foundation.
Searching for the best tax incentives in European R&D? Then look no further than the Science|Business guide to this popular - though by no means universal - stimulant.
Spend more on basic research - that's one of the prescriptions for Europe offered by Jim Goodnight, founder and CEO of SAS, one of the world's largest privately held software companies.
Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.
Hailed as one of the most important recent discoveries in biology, RNA interference has seen patent applications rise 3,000 per cent between 2000 and 2003.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.